(2023). Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study. Eclinicalmedicine, 58, 101932. http://doi.org/10.1016/j.eclinm.2023.101932.
(2020). Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with Ibuprofen. Drug Saf. http://doi.org/10.1007/s40264-020-00950-3.
(2021). Quantifying bias in epidemiologic studies evaluating the association between acetaminophen use and cancer. Regul Toxicol Pharmacol. http://doi.org/10.1016/j.yrtph.2021.104866.